Indevus's microbicide gel shows encouraging signs of preventing HIV
This article was originally published in Scrip
Executive Summary
Indevus Pharmaceuticals' PRO 2000 (naphthalene sulfonate polymer), the most advanced microbicide gel in development, has shown encouraging signs in preventing HIV infection in women in a study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US NIH. Meanwhile, ReProtect's BufferGel failed to show any signs of efficacy.